Author

Abdelrahman M.G. Yousef

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-7761-8149Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andrea VialeiD· 1 shared Ashlee Nichole SeldomridgeiD· 1 shared Beth Helmink· 1 shared Ching-Fei LiiD· 1 shared Dan ZhaoiD· 1 shared David H. PengiD· 1 shared David S. HongiD· 1 shared Dean N. PaniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrea VialeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Hematology & OncologyPeer-reviewedJul 2, 2026

KRAS inhibition is an effective therapy for appendiceal adenocarcinoma

Saikat Chowdhury, Ichiaki Ito, Vinay K. Pattalachinti…·John Paul Shen

This study evaluates KRAS inhibitors in appendiceal adenocarcinoma models and patients, showing efficacy in reducing tumor growth and suggesting potential resistance mechanisms.

2 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedSep 18, 2025

KRAS inhibition activates an actionable CD24 do-not-eat-me signal in pancreatic cancer

Yongkun Wei, Minghui Liu, Er-Yen Yen…·Haoqiang Ying

This study identifies CD24 as an actionable signal activated by KRASG12C inhibition in pancreatic cancer, enhancing macrophage phagocytosis and sensitizing tumors to therapy.

6 citations

mouseproteomics

𝕏 PostBluesky